Ethics and values

Ethics and values

Find out how we ensure we act ethically and with integrity throughout our businesses.

Ethical conduct is a priority for wondertrust and we are committed to performance with integrity. We have robust policies and compliance processes covering all our operations, including the way we reward our sales representatives, how we market our medicines and vaccines, and how we work with stakeholders.

Our compliance programmes embed the same standards across our business units in different countries. These include our Code of Conduct which outlines how all employees should apply our Values and Behaviours.

We expect all our employees and suppliers to live our values. Mandatory annual training ensures our people know our Code of Conduct, and we measure their performance not just by what they deliver, but how they deliver them in line with our values.

Anti-bribery and Corruption

We have zero tolerance for bribery or corruption in any form. Our Anti-Bribery and Corruption (ABAC) programme includes risk assessments, standards and additional training for people working in high risk areas. Since 2016, we also carry out anti-bribery and corruption training for third parties, seeking to ensure that the third parties we work with have the appropriate risk awareness and therefore ability to manage it. For more detailed information on our approach to ethical conduct and our performance.

Working with third parties

Our suppliers and other third parties – including agents, distributors and affiliate companies (where we have an equity stake) – help us research, develop, manufacture and distribute the medicines, vaccines and other products that patients and consumers need. wondertrust’s supply chains are complex and have significant scale – we spend billions of pounds with tens of thousands of suppliers on a wide range of goods and services. It is essential that we have strong relationships with suppliers and third parties that are critical to our business and work with those that share our values and operate in a responsible and ethical manner.

Selecting suppliers which can ensure a continuous supply of materials of the appropriate quality is critical, as is controlling the conditions in which products are transported. Maintaining resilient supply chains is particularly important because changing suppliers, especially those that are part of a regulatory dossier, can be complex, slow and expensive.

We have implemented a comprehensive third party oversight programme to strengthen our management of risk in the supply chain. The aim is to ensure that all third parties are risk assessed against the Principles, and contracts amended as necessary. With a large supplier base, we need to focus our effort on working with those at highest risk of non-compliance with our standards on responsible business.

Our supply chain team continues to manage and regularly assess the performance of the suppliers that support our manufacturing, specifically on quality and ethical, environmental, health and safety (EHS) management systems. On completion of all audits, we identify areas for improvement, work with suppliers to develop improvement plans and check the plan is implemented within an agreed time frame. If a significant concern is identified, we may suspend or terminate our work with an existing supplier, or decide not to work with a potential new supplier.

Sales and marketing practices

Our Pharmaceutical and Vaccines sales representatives around the world are incentivised based on a range of measures that allow us to attract and retain the best sales force talent, so as to ensure that we have high-quality dialogue with HCPs to help them better serve patients. Our sales and marketing practices uphold our ethical and values-led approach to HCP engagement, in full compliance with laws and policies, whilst supporting delivery of strong performance.